Search filters

List of works by Mark Veselov

AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models.

scientific article published on 7 November 2016

Common features of antibacterial compounds: an analysis of 104 compounds library

scientific article published in November 2015

Computational approaches to the design of novel 5-HT6 R ligands.

scientific article published on January 2014

Computational insight into the chemical space of plant growth regulators.

scientific article published on 23 December 2015

Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists.

scientific article published on 2 June 2015

Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors

scientific article

Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025).

scientific article

Identification of Novel Small-Molecule ASGP-R Ligands

scientific article published on 19 July 2016

Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.

scientific article published on 9 May 2015

Novel oral anti-influenza drug candidate AV5080.

scientific article published on 11 April 2014

Novel oral anti-influenza prodrug candidate AV5075S.

scientific article published on 15 January 2014

Small-molecule PSMA ligands. Current state, SAR and perspectives.

scientific article published on 18 February 2016

Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives.

scientific article published on 2 January 2016